메뉴 건너뛰기




Volumn 14, Issue 1, 2003, Pages 212-221

Vanadyl-thiazolidinedione combination agents for diabetes therapy

Author keywords

[No Author keywords available]

Indexed keywords

CHELATION; LIGANDS; VANADIUM COMPOUNDS;

EID: 0037260712     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc025606m     Document Type: Article
Times cited : (49)

References (42)
  • 2
    • 0021991110 scopus 로고
    • Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats
    • Heyliger, C. E., Tahiliani, A. G., and McNeill, J. H. (1985) Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. Science 227, 1474-1477.
    • (1985) Science , vol.227 , pp. 1474-1477
    • Heyliger, C.E.1    Tahiliani, A.G.2    McNeill, J.H.3
  • 3
    • 0030017672 scopus 로고    scopus 로고
    • Evidence for the distinct vanadyl(+4)-dependent activating system for manifesting insulin-like effects
    • Li, J., Elberg, G., Crans, D. C., and Shechter, Y. (1996) Evidence for the distinct vanadyl(+4)-dependent activating system for manifesting insulin-like effects. Biochemistry 35, 8314-8318.
    • (1996) Biochemistry , vol.35 , pp. 8314-8318
    • Li, J.1    Elberg, G.2    Crans, D.C.3    Shechter, Y.4
  • 4
    • 0028097699 scopus 로고
    • Vanadate augments insulin-stimulated insulin receptor kinase activity and prolongs insulin action in rat adipocytes. Evidence for transduction of amplitude of signaling into duration of response
    • Fantus, I. G., Ahmad, F., and Deragon, G. (1994) Vanadate augments insulin-stimulated insulin receptor kinase activity and prolongs insulin action in rat adipocytes. Evidence for transduction of amplitude of signaling into duration of response. Diabetes 43, 375-383.
    • (1994) Diabetes , vol.43 , pp. 375-383
    • Fantus, I.G.1    Ahmad, F.2    Deragon, G.3
  • 6
    • 0029618093 scopus 로고
    • Insulin-like actions of vanadate are mediated in an insulin-receptor-independent manner via nonreceptor protein tyrosine kinases and protein phosphotyrosine phosphatases
    • Shechter, Y., Li, J., Meyerovitch, J., Gefel, D., Bruck, R., Elberg, G., Miller, D. S., and Shisheva, A. (1995) Insulin-like actions of vanadate are mediated in an insulin-receptor-independent manner via nonreceptor protein tyrosine kinases and protein phosphotyrosine phosphatases. Mol. Cell. Biochem. 153, 39-47.
    • (1995) Mol. Cell. Biochem. , vol.153 , pp. 39-47
    • Shechter, Y.1    Li, J.2    Meyerovitch, J.3    Gefel, D.4    Bruck, R.5    Elberg, G.6    Miller, D.S.7    Shisheva, A.8
  • 7
    • 0027490006 scopus 로고
    • Mechanism of pervanadate stimulation and potentiation of insulin-activated glucose transport in rat adipocytes: Dissociation from vanadate effect
    • Shisheva, A., and Shechter, Y. (1993) Mechanism of pervanadate stimulation and potentiation of insulin-activated glucose transport in rat adipocytes: dissociation from vanadate effect. Endocrinology 133, 1562-1568.
    • (1993) Endocrinology , vol.133 , pp. 1562-1568
    • Shisheva, A.1    Shechter, Y.2
  • 8
    • 0023219921 scopus 로고
    • Oral administration of vanadate normalizes blood glucose evels in streptozotocin-treated rats. Characterization and mode of action
    • Meyerovitch, J., Farfel, Z., Sack, J., and Shechter, Y. (1987) Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats. Characterization and mode of action. J. Biol. Chem. 262, 6658-6662.
    • (1987) J. Biol. Chem. , vol.262 , pp. 6658-6662
    • Meyerovitch, J.1    Farfel, Z.2    Sack, J.3    Shechter, Y.4
  • 9
  • 10
    • 0030937116 scopus 로고    scopus 로고
    • Vanadium compounds. Biological actions and potential as pharmacological agents
    • Tsiani, E., and Fantus, I. G. (1997) Vanadium compounds. Biological actions and potential as pharmacological agents. Trends Endocrinol. Metab. 8, 51-58.
    • (1997) Trends Endocrinol. Metab. , vol.8 , pp. 51-58
    • Tsiani, E.1    Fantus, I.G.2
  • 11
    • 0043229404 scopus 로고    scopus 로고
    • Chemical and pharmacological studies of a new class of antidiabetic vanadium complexes
    • ACS Symposium Series 711, American Chemical Society, New York
    • Thompson, K. H., Yuen, V. G., McNeill, J. H., and Orvig, C. (1998) Chemical and pharmacological studies of a new class of antidiabetic vanadium complexes. In Chemistry, Biochemistry and Therapeutic Applications, ACS Symposium Series 711, pp 329, American Chemical Society, New York.
    • (1998) Chemistry, Biochemistry and Therapeutic Applications , pp. 329
    • Thompson, K.H.1    Yuen, V.G.2    McNeill, J.H.3    Orvig, C.4
  • 13
    • 0026642054 scopus 로고
    • Bis(maltolato)oxovanadium(IV) is a potent insulin mimic
    • McNeill, J. H., Yuen, V. G., Hoveyda, H. R., and Orvig, C. (1992) Bis(maltolato)oxovanadium(IV) is a potent insulin mimic. J. Med. Chem. 35, 1489-1491.
    • (1992) J. Med. Chem. , vol.35 , pp. 1489-1491
    • McNeill, J.H.1    Yuen, V.G.2    Hoveyda, H.R.3    Orvig, C.4
  • 14
    • 0028957653 scopus 로고
    • Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration
    • Yuen, V. G., Orvig, C., and McNeill, J. H. (1995) Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration. Can. J. Physiol. Pharmacol. 73, 55-64.
    • (1995) Can. J. Physiol. Pharmacol. , vol.73 , pp. 55-64
    • Yuen, V.G.1    Orvig, C.2    McNeill, J.H.3
  • 15
    • 0029618689 scopus 로고
    • Increased potency of vanadium using organic ligands
    • McNeill, J. H., Yuen, V. G., Dai, S., and Orvig, C. (1995) Increased potency of vanadium using organic ligands. Mol. Cell. Biochem. 153, 175-180.
    • (1995) Mol. Cell. Biochem. , vol.153 , pp. 175-180
    • McNeill, J.H.1    Yuen, V.G.2    Dai, S.3    Orvig, C.4
  • 16
    • 0030821383 scopus 로고    scopus 로고
    • Glucose-lowering properties of vanadium compounds: Comparison of coordination complexes with maltol or kojic acid as ligands
    • Yuen, V. G., Caravan, P., Gelmini, L., Glover, N., McNeill, J. H., Setyawati, I. A., Zhou, Y., and Orvig, C. (1997) Glucose-lowering properties of vanadium compounds: comparison of coordination complexes with maltol or kojic acid as ligands. J. Inorg. Biochem. 68, 109-116.
    • (1997) J. Inorg. Biochem. , vol.68 , pp. 109-116
    • Yuen, V.G.1    Caravan, P.2    Gelmini, L.3    Glover, N.4    McNeill, J.H.5    Setyawati, I.A.6    Zhou, Y.7    Orvig, C.8
  • 18
    • 0029049705 scopus 로고
    • Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with noninsulin-dependent diabetes mellitus
    • Cohen, N., Halberstam, M., Shlimovich, P., Chang, C. J., Shamoon, H., and Rossetti, L. (1995) Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with noninsulin-dependent diabetes mellitus. J. Clin. Invest. 95, 2501-2509.
    • (1995) J. Clin. Invest. , vol.95 , pp. 2501-2509
    • Cohen, N.1    Halberstam, M.2    Shlimovich, P.3    Chang, C.J.4    Shamoon, H.5    Rossetti, L.6
  • 20
    • 0032080751 scopus 로고    scopus 로고
    • Troglitazone: An antidiabetic agent
    • Chen, C. (1998) Troglitazone: an antidiabetic agent. Am. J. Health-Syst. Pharm. 55, 905-925.
    • (1998) Am. J. Health-Syst. Pharm. , vol.55 , pp. 905-925
    • Chen, C.1
  • 23
    • 0031203282 scopus 로고    scopus 로고
    • Troglitazone
    • Santiago, J. V. (1997) Troglitazone. Compr. Ther. 23, 560-562.
    • (1997) Compr. Ther. , vol.23 , pp. 560-562
    • Santiago, J.V.1
  • 24
    • 0032484224 scopus 로고    scopus 로고
    • A potent antidiabetic thiazoldinedione with unique peroxisome proliferator-activated receptor γ-activating properties
    • Raginato, M. J., Bailey, S. T., Krakow, S. L., Minami, C., Ishii, S., Tanaka, H., and Lazar, M. A. (1998) A potent antidiabetic thiazoldinedione with unique peroxisome proliferator-activated receptor γ-activating properties. J. Biol. Chem. 273, 32679-32684.
    • (1998) J. Biol. Chem. , vol.273 , pp. 32679-32684
    • Raginato, M.J.1    Bailey, S.T.2    Krakow, S.L.3    Minami, C.4    Ishii, S.5    Tanaka, H.6    Lazar, M.A.7
  • 25
    • 0001178747 scopus 로고
    • Neutral water-soluble post-transition-metal chelate complexes of medical interest: Aluminum and gallium tris(3-hydroxy-4-pyronates)
    • Finnegan, M. M., Lutz, T. G., Nelson, W. O., Smith, A., and Orvig, C. (1987) Neutral water-soluble post-transition-metal chelate complexes of medical interest: aluminum and gallium tris(3-hydroxy-4-pyronates). Inorg. Chem. 26, 2171-2176.
    • (1987) Inorg. Chem. , vol.26 , pp. 2171-2176
    • Finnegan, M.M.1    Lutz, T.G.2    Nelson, W.O.3    Smith, A.4    Orvig, C.5
  • 27
    • 84981834578 scopus 로고
    • Heilmittelchemische studien in der heterocyclischen reihe. Die reaktion von kojisaure mit hydrazin. Umsetzung von kojisaureathern mit hydrazin
    • Thomas, A. F., and Marxer, A. (1960) Heilmittelchemische studien in der heterocyclischen reihe. Die reaktion von kojisaure mit hydrazin. Umsetzung von kojisaureathern mit hydrazin. Helv. Chim. Acta 61, 469-477.
    • (1960) Helv. Chim. Acta , vol.61 , pp. 469-477
    • Thomas, A.F.1    Marxer, A.2
  • 28
    • 0020353926 scopus 로고
    • Studies on antidiabetic agents. II. Synthesis of 5-[4-(1-methylcyclohexylmethoxy)-benzyl]-thiazolidine-2,4-dione (ADD-3878) and its derivatives
    • Sohda, T., Mizuno, K., Imamiya, E., Sugiyama, Y., Fujita, T., and Kawamatsu, Y. (1982) Studies on antidiabetic agents. II. Synthesis of 5-[4-(1-methylcyclohexylmethoxy)-benzyl]-thiazolidine-2,4-dione (ADD-3878) and its derivatives. Chem. Pharm. Bull. 30, 3580-3600.
    • (1982) Chem. Pharm. Bull. , vol.30 , pp. 3580-3600
    • Sohda, T.1    Mizuno, K.2    Imamiya, E.3    Sugiyama, Y.4    Fujita, T.5    Kawamatsu, Y.6
  • 30
    • 0030459837 scopus 로고    scopus 로고
    • Synthesis and biological activity of metabolites of the antidiabetic, antihyperglycemic agent pioglitazone
    • Tanis, S. P., Parker, T. T., Colca, J. R., Fisher, R. M., and Kletzein, R. F. (1996) Synthesis and biological activity of metabolites of the antidiabetic, antihyperglycemic agent pioglitazone. J. Med. Chem. 39, 5053-5063.
    • (1996) J. Med. Chem. , vol.39 , pp. 5053-5063
    • Tanis, S.P.1    Parker, T.T.2    Colca, J.R.3    Fisher, R.M.4    Kletzein, R.F.5
  • 31
    • 0022481505 scopus 로고
    • A neutral water-soluble aluminum complex of neurological interest
    • Finnegan, M. M., Rettig, S. J., and Orvig, C. (1986) A neutral water-soluble aluminum complex of neurological interest. J. Am. Chem. Soc. 108, 5034-5035.
    • (1986) J. Am. Chem. Soc. , vol.108 , pp. 5034-5035
    • Finnegan, M.M.1    Rettig, S.J.2    Orvig, C.3
  • 32
    • 0001066765 scopus 로고
    • 2O. A facial geometry imposed by extensive hydrogen bonding with the ice I structure
    • 2O. A facial geometry imposed by extensive hydrogen bonding with the ice I structure. J. Am. Chem. Soc. 109, 4121-4123.
    • (1987) J. Am. Chem. Soc. , vol.109 , pp. 4121-4123
    • Nelson, W.O.1    Rettig, S.J.2    Orvig, C.3
  • 33
    • 0001243674 scopus 로고
    • Chemistry of kojic acid: One-step syntheses of benzothiazoles and other fused heterocycles from kojic acid derivatives
    • Teitei, T. (1983) Chemistry of kojic acid: one-step syntheses of benzothiazoles and other fused heterocycles from kojic acid derivatives. Aust. J. Chem. 36, 2307.
    • (1983) Aust. J. Chem. , vol.36 , pp. 2307
    • Teitei, T.1
  • 38
    • 0000032952 scopus 로고    scopus 로고
    • Characterization of the potent insulin mimetic agent bis(maltolato)-oxovanadium(IV) (BMOV) in solution by EPR spectroscopy
    • Hanson, G. R., Sun, Y., and Orvig, C. (1996) Characterization of the potent insulin mimetic agent bis(maltolato)-oxovanadium(IV) (BMOV) in solution by EPR spectroscopy. Inorg. Chem. 35, 6507-6512.
    • (1996) Inorg. Chem. , vol.35 , pp. 6507-6512
    • Hanson, G.R.1    Sun, Y.2    Orvig, C.3
  • 41
    • 12244286000 scopus 로고    scopus 로고
    • Manuscript in preparation
    • Yuen, V. G., and McNeill, J. H. (2002) Manuscript in preparation.
    • (2002)
    • Yuen, V.G.1    McNeill, J.H.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.